View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Market Data
September 8, 2016

M&As this week: Asahi Glass, Allergan

Asahi Glass has acquired Biomeva from Biomeva Holding to expand its business.

Asahi Glass has acquired Biomeva from Biomeva Holding to expand its business.

The acquirer is a glass company, while the target company is a contract manufacturing business that manufactures and distributes biologics, APIs and therapeutic proteins.

Allergan has acquired all assets of RetroSense Therapeutics LLC to expand its ongoing development programmes.

According to the agreement, RetroSense will receive an upfront payment of $60m, as well as an additional regulatory and commercialisation milestone payments for its proprietary gene therapy RST-100 from Allergan.


Image: Allergan Plc has acquired all the assets of RetroSense Therapeutics LLC. Photo: Courtesy of Coolcaesar at the English language Wikipedia.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena